Skip to content
November 03, 2026

Equity.Guru

Investment information for the new generation

Search

Biotech

10 September 2026 Cannabix (BLO.C) finally has a marijuana breath test, 10…
10 September 2026
Cannabix (BLO.C) finally has a marijuana breath test, 10 years…
There are few phrases in the junior markets more dangerous than “in the coming weeks.” “In the coming months” is another good one. “Soon enter the market” should probably…
23 January 2025 Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up…
23 January 2025
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400%…
Hemostenix (HEM.V) has been lifting off of late, and as we’ve seen some real upward movement in the pharmaceuticals/biotech space in Canada of late (See Onco Innovations and Voyageur…
8 January 2025 Can your phone confirm you have strep throat? Light…
8 January 2025
Can your phone confirm you have strep throat? Light AI…
Light AI’s claim: That it can revolutionize health diagnostics with your smartphone Imagine a world where diagnosing illnesses is as easy as snapping a picture of yourself with your…
28 October 2024 Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug…
28 October 2024
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt Solutions Inc. (BNXT.C), a bioscience…
16 July 2024 Pubcos extending warrants as summer drags on, hoping for…
16 July 2024
Pubcos extending warrants as summer drags on, hoping for cash…
Canadian-listed, German-based bioscience accelerator BioNxt (BNXT.C) has announced it plans to give warrant holders an additional year to exercise 2022-purchased $0.50 warrants of the company, as its stock steadily…
2 July 2024 BioNxt Solutions (BNXT.C) to spark marketing as ODF human…
2 July 2024
BioNxt Solutions (BNXT.C) to spark marketing as ODF human studies…
Biotech companies are notoriously difficult to find investor love for in Canada, at least historically, so it’s no surprise that BioNxt Solutions (BNXT.C) is headquartered in Germany. That proximity…
24 April 2024 Zentek (ZEN.V) took a years long path to figure…
24 April 2024
Zentek (ZEN.V) took a years long path to figure out…
Today I found myself going down an investment rabbit hole, chasing information about a company that, to be honest, is wallowing, and has for a while. Unmarketed. Unexplained. Unsimple….
27 March 2024 Revive Therapeutics (RVV.CN) submits package to FDA for long…
27 March 2024
Revive Therapeutics (RVV.CN) submits package to FDA for long term…
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…
26 March 2024 Medexus (MDP.TO) announces FDA approval for IXINITY to treat…
26 March 2024
Medexus (MDP.TO) announces FDA approval for IXINITY to treat hemophilia…
Specialty pharmaceuticals is a unique niche in the pharma sector. Where companies like Eli Lilly pour billions into developing a drug candidate from scratch with the very real possibility…
19 March 2024 Revive Therapeutics (RVV.CN) to submit meeting request with FDA…
19 March 2024
Revive Therapeutics (RVV.CN) to submit meeting request with FDA for…
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…